-
Critical new health project, WISH 2 Lot 1, will expand reproductive choice in West and Central Africa
MSI Reproductive Choices and its partners announce a critical new health project, WISH 2 Lot 1, which will bring quality sexual and reproductive healthcare services to millions of women and girls across six countries in West and Central Africa.
-
Our Clinton Global Initiative Commitment
Our Clinton Global Initiative with Blue Ventures will expand on successes in Madagascar to support the resilience of 1.5 million people in sub-Saharan coastal communities.
-
MSI Statement on Abortion Clinic ‘Safe Access Zones’
The UK Government has announced that Safe Access Zones around abortion clinics will be implemented from 31st October in England and Wales, preventing anti-choice groups from harassing those seeking and providing abortion care. MSI Reproductive …
-
MSI named a ‘very high-performer’ in 2024 gender equity and inclusion report
In the latest Global Health 50/50 Report, which looks at the gender-related policies and practices of more than 200 organisations in global health, we’re proud that MSI has been rated a ‘very high performer’.
-
MSI appoints Dr Carole Sekimpi as Senior Director for Africa
MSI is delighted to announce that Dr Carole Sekimpi is our new Senior Director for Africa.
-
MSI at the Healthy World conference in Canada: linking climate and reproductive health
Working together to mitigate the effects of climate change and help build community resilience — with women’s reproductive health.
-
MSI welcomes Beth Schlachter as Senior Director of US External Relations
MSI is delighted to announce that Beth Schlachter has joined our organisation in the United States as the Senior Director of US External Relations.
-
New Guttmacher report shows long-term harms of US Global Gag Rule in Ethiopia and Uganda
The Guttmacher Institute today published a multi-year research study which reveals the U.S. Global Gag Rule (GGR) disrupted critical health services affecting women and girls in Uganda and Ethiopia – two countries that rely on U.S. assistance for their family planning programmes.
-
Advocacy win: Mifepristone registered in Tanzania
MSI and partners have successfully advocated to have mifepristone – the second of two medications used for abortion and post-abortion care – registered and authorised for use in Tanzania.
-
MSI meets with Canadian Officials to discuss commitment to choice
From 25-27th March, MSI was proud to meet with Canadian Officials and Global Affairs Canada, to discuss the incredible impact Canada is making on health, lives, and futures around the world, with their support for reproductive choice.
